Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Scientific Introduces Next Generation Ion Chromatography Suppressor

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
The Thermo Scientific™ Dionex™ ERS™ 500 Electrolytically Regenerated Suppressor replaces the Thermo Scientific™ Dionex™ SRS™ 300 Self Regenerating Suppressor.

The Dionex ERS 500 Suppressor minimizes dispersion to deliver higher resolution separations, especially when coupled with Thermo Scientific™ Dionex™ 4 µm based IC columns. The Dionex ERS 500 suppressor permits improved compatibility with a wider range of detection techniques including MS, ICP, ICP-MS etc. due to its improved backpressure resilience. Additionally, the Dionex ERS 500 suppressor precludes the need for periodic chemical regeneration, allowing for greater ease of use and reproducibility.

Eluent suppression technology allows for a wide variety of inorganic and organic analyses for ion chromatography applications such as environmental, high purity water, semiconductor, high purity chemicals, food and beverage, pharmaceutical and process monitoring. Suppression greatly enhances signal-to-noise ratio by decreasing the background conductivity of the eluent and associated noise while simultaneously increasing analyte conductivity.

The Dionex ERS 500 is an electrolytic suppressor with a new hardware design that allows the suppressor to be more pressure tolerant than previous generation suppressor devices.  The suppressor flow pathway has been redesigned to optimize band dispersion and improve the flow and sealing properties.

“We invented eluent suppression years ago to help make ion chromatography a mainstream technique,” said Chris Pohl, Thermo Fisher vice president, chromatography chemistry. “We’ve never stopped striving to improve the usefulness of the technique, and this new suppressor is an example of this relentless innovation.”

The Dionex ERS 500 suppressor is truly the next generation in suppression technology, significantly improving ruggedness without sacrificing performance or ease-of-use.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Advancing Lithium-Ion Battery Research
The increasing number of components in a lithium-ion battery makes it essential to use a variety of analytical methods to attain complete characterization.
Wednesday, October 28, 2015
Automating Deep Characterization of Biotherapeutic Proteins
Thermo's new PepFinder software streamlines relative and absolute quantitation, and identification of proteins from biological samples using LC-MS.
Thursday, June 19, 2014
Thermo Scientific Chromatography Columns/Consumables Catalog Goes Mobile
2014-15 Chromatography Columns and Consumables Catalog now available in print, pdf and interactive mobile versions.
Thursday, February 27, 2014
Thermo Collaborates with Leading EU and UK Pesticide Testing Labs
The company's Pesticide Analysis Center of Excellence provides technology, consultation and support.
Tuesday, November 19, 2013
Thermo Scientific at ASMS 2013
Learn how scientists and researchers are transforming science by applying innovative solutions to a wide range of qualitative and quantitative applications.
Monday, May 13, 2013
Thermo Fisher Scientific Reports First Quarter 2013 Results
Adjusted earnings per share grew 17% to a record $1.37 with revenue increased 4% to a first quarter record of $3.19 billion.
Thursday, April 25, 2013
Thermo Fisher Scientific to Acquire Life Technologies
Transaction expected to create an unrivaled leader in serving research, specialty diagnostics and applied markets.
Wednesday, April 17, 2013
Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Thermo Fisher Scientific Facilities Achieve ISO 13485 Certification
The facilities in San Jose, CA and Franklin, MA have achieved the internationally recognized standard of quality management for the design and manufacture of medical devices.
Thursday, April 04, 2013
Thermo Fisher Scientific to Acquire picoSpin
Thermo Fisher Scientific Inc. has completed a purchase of picoSpin, LLC, creators of the world’s first miniature NMR spectrometer.
Friday, December 21, 2012
Hyperion Succesfully Completes Laboratory Infrastructure Project for Hellenic Petroleum
Hyperion and the Hellenic Petroleum Group have completed a major upgrade and extension project for the LIMS at three Greek petroleum refineries of the Group.
Wednesday, November 21, 2012
Thermo Fisher Scientific Reports Q3 Revenue and EPS Results
Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.
Wednesday, October 24, 2012
Thermo Fisher Scientific and Immundiagnostik Collaborate
The collaboration aims to develop novel mass spectrometry-based assays for qualitative and quantitative analysis of proteins and peptides.
Wednesday, October 17, 2012
Thermo Fisher Scientific and bioMérieux Renew Partnership
The companies have renewed their non-exclusive, long-term, royalty-bearing agreement for Procalcitonin testing.
Wednesday, October 03, 2012
Seminars on Advanced Solutions for Nutraceutical Analysis
Seminar sessions will discuss Company’s chromatography and elemental analysis techniques to optimize nutraceutical processes.
Tuesday, September 25, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Analysis Technique for Chiral Activity in Molecules
Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Antibiotics on Our Plates 'Could Lead to Health Catastrophe'
Two medical experts from The University of Queensland are urging China to curb its use of antibiotics in animals to avoid what could be a ‘major health catastrophe’ for humans.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos